Free Trial

Amprius Technologies (NYSE:AMPX) Shares Up 5.5% - Still a Buy?

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares jumped 5.5% to about $10.01 on Monday on volume ~34% above average, giving Amprius a market cap near $1.31 billion.
  • Street analysts show a Moderate Buy consensus with an average price target of $14.57 (seven Buys, one Sell), and several firms have raised targets into the $14–$20 range.
  • Amprius beat the quarter (EPS -$0.03 vs. -$0.06; revenue $21.4M vs. $16.45M) but remains unprofitable with negative margins and a -$0.45 EPS outlook for the year, and insiders have sold material stakes — the CEO sold 1,000,000 shares.
  • MarketBeat previews the top five stocks to own by May 1st.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) shares traded up 5.5% during mid-day trading on Monday . The stock traded as high as $10.42 and last traded at $10.0060. 8,836,470 shares changed hands during trading, an increase of 34% from the average session volume of 6,573,297 shares. The stock had previously closed at $9.48.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AMPX. Oppenheimer reiterated an "outperform" rating and issued a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Northland Securities set a $20.00 target price on Amprius Technologies in a research report on Tuesday, October 7th. Cantor Fitzgerald lifted their price target on shares of Amprius Technologies from $12.00 to $16.00 and gave the stock an "overweight" rating in a research note on Friday, November 7th. Roth Capital set a $14.00 price objective on shares of Amprius Technologies and gave the company a "buy" rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, October 8th. Seven equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $14.57.

Read Our Latest Analysis on Amprius Technologies

Amprius Technologies Stock Up 5.5%

The business has a 50-day simple moving average of $10.38 and a two-hundred day simple moving average of $9.49. The stock has a market capitalization of $1.31 billion, a P/E ratio of -38.48 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.03. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. The company had revenue of $21.43 million for the quarter, compared to the consensus estimate of $16.45 million. On average, sell-side analysts forecast that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Insider Transactions at Amprius Technologies

In other Amprius Technologies news, CEO Kang Sun sold 1,000,000 shares of the company's stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $10.60, for a total transaction of $10,600,000.00. Following the sale, the chief executive officer directly owned 1,472,306 shares of the company's stock, valued at approximately $15,606,443.60. This represents a 40.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CTO Constantin Ionel Stefan sold 198,255 shares of Amprius Technologies stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $10.51, for a total transaction of $2,083,660.05. Following the completion of the transaction, the chief technology officer owned 748,696 shares of the company's stock, valued at $7,868,794.96. This trade represents a 20.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 1,291,934 shares of company stock worth $13,627,944. Company insiders own 12.80% of the company's stock.

Hedge Funds Weigh In On Amprius Technologies

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Voloridge Investment Management LLC acquired a new stake in shares of Amprius Technologies in the third quarter valued at $19,737,000. BNP Paribas Financial Markets grew its holdings in Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company's stock worth $20,450,000 after acquiring an additional 1,784,291 shares during the last quarter. Vanguard Group Inc. increased its position in Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company's stock valued at $68,513,000 after acquiring an additional 1,757,395 shares in the last quarter. Invesco Ltd. raised its stake in shares of Amprius Technologies by 113.3% in the third quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock worth $25,031,000 after acquiring an additional 1,263,846 shares during the last quarter. Finally, Stephens Investment Management Group LLC bought a new position in shares of Amprius Technologies in the third quarter worth about $11,392,000. Institutional investors and hedge funds own 5.04% of the company's stock.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines